Sunil Patel - Net Worth and Insider Trading

Sunil Patel Net Worth

The estimated net worth of Sunil Patel is at least $4 Million dollars as of 2024-11-13. Sunil Patel is the Director of Ligand Pharmaceuticals Inc and owns about 28,190 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. Sunil Patel is the Director of OmniAb Inc and owns about 215,512 shares of OmniAb Inc (OABI) stock worth over $967,649. Sunil Patel is also the See Remarks of OncoMed Pharmaceuticals Inc and owns about 68,336 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $60,819. Details can be seen in Sunil Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sunil Patel has not made any transactions after 2022-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sunil Patel

To

Sunil Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sunil Patel owns 4 companies in total, including Ligand Pharmaceuticals Inc (LGND) , OncoMed Pharmaceuticals Inc (OMED) , and Avista Public Acquisition Corp II (AHPA) among others .

Click here to see the complete history of Sunil Patel’s form 4 insider trades.

Insider Ownership Summary of Sunil Patel

Ticker Comapny Transaction Date Type of Owner
LGND Ligand Pharmaceuticals Inc 2020-11-02 director
OMED OncoMed Pharmaceuticals Inc 2018-01-04 See Remarks
AHPA Avista Public Acquisition Corp II 2022-11-01 director
LIMIT LIMIT 2022-11-09 director

Sunil Patel Latest Holdings Summary

Sunil Patel currently owns a total of 3 stocks. Among these stocks, Sunil Patel owns 28,190 shares of Ligand Pharmaceuticals Inc (LGND) as of November 2, 2020, with a value of $3 Million and a weighting of 76.8%. Sunil Patel owns 215,512 shares of OmniAb Inc (OABI) as of November 9, 2022, with a value of $967,649 and a weighting of 21.83%. Sunil Patel also owns 68,336 shares of OncoMed Pharmaceuticals Inc (OMED) as of October 10, 2017, with a value of $60,819 and a weighting of 1.37%.

Latest Holdings of Sunil Patel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LGND Ligand Pharmaceuticals Inc 2020-11-02 28,190 120.74 3,403,661
OABI OmniAb Inc 2022-11-09 215,512 4.49 967,649
OMED OncoMed Pharmaceuticals Inc 2017-10-10 68,336 0.89 60,819

Holding Weightings of Sunil Patel


Sunil Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Sunil Patel has made a total of 1 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ligand Pharmaceuticals Inc is the acquisition of 1,000 shares on November 2, 2020, which cost Sunil Patel around $82,520.

According to the SEC Form 4 filings, Sunil Patel has made a total of 1 transactions in OmniAb Inc (OABI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OmniAb Inc is the acquisition of 43,000 shares on November 9, 2022, which cost Sunil Patel around $119,110.

According to the SEC Form 4 filings, Sunil Patel has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 1,248 shares on October 10, 2017, which brought Sunil Patel around $5,292.

Insider Trading History of Sunil Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sunil Patel Trading Performance

GuruFocus tracks the stock performance after each of Sunil Patel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sunil Patel is 37.83%. GuruFocus also compares Sunil Patel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sunil Patel within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sunil Patel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sunil Patel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
6 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.13 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Sunil Patel Ownership Network

Ownership Network List of Sunil Patel

No Data

Ownership Network Relation of Sunil Patel

Insider Network Chart

Sunil Patel Owned Company Details

What does Ligand Pharmaceuticals Inc do?

Who are the key executives at Ligand Pharmaceuticals Inc?

Sunil Patel is the director of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .

Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary

Over the past 18 months, Sunil Patel made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .

In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ligand Pharmaceuticals Inc Insider Transactions

No Available Data

Sunil Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Sunil Patel. You might contact Sunil Patel via mailing address: 11085 North Torrey Pines Rd., Suite 300, La Jolla Ca 92037.